Quick Test Minimizes Unnecessary Primary Care Antibiotic Prescribing
By LabMedica International staff writers Posted on 19 Oct 2015 |
C-reactive protein (CRP) is a biomarker in blood which indicates the presence of inflammation, and the amount of CRP in the body gives an indication of the severity of an infection. Low levels of CRP are indicative of viral or self-limiting bacterial infections, and high levels indicate serious infection.
Almost 80% of antibiotics are prescribed in primary care and respiratory tract infections (RTIs) are the reason for 60% of these antibiotic prescriptions. The vast majority of these infections are self-limiting or caused by viruses in which case antibiotics have little or no clinical benefit for patients. C-reactive protein point of care testing (CRP POCT) has successfully helped to identify patients who did not require antibiotics, when presenting with symptoms of RTIs.
A study that was recently conducted that included 99 patients, aged 5 to 75 years who visited their general practitioner (GP) with a chesty cough. After undergoing a clinical scoring system, each patient's CRP levels were measured at the point of care using the Afinion CRP test, a rapid in vitro diagnostic assay for quantitative determination of CRP (Alere; Waltham, MA, USA). Only 13% of these patients needed antibiotic treatment as the CRP POCT had concluded higher CRP levels. Within one month, 17% of the 99 patients returned to the surgery and only 5% were prescribed antibiotics.
The study also provides insights on patients' expectations of receiving antibiotics. All participants had to complete a questionnaire in which they were asked whether they expected to receive antibiotics for their symptoms. Of the 26 patients expecting to receive antibiotics, only seven (27%) patients received them. Additionally, patients with lower CRP levels, who therefore would not have been suitable for antibiotics, were more likely to expect an antibiotic when asked.
CRP POCT takes less than five minutes from a finger stick blood sample to provide a quantitative result and helps to facilitate an effective conversation between patients and GPs around the rational use of antibiotics. The CRP POCT is already used in routine management in several European countries to aid diagnosis in suspected RTI and guide decision making regarding antibiotic prescribing.
Rob Cook, MD, who was involved in the study and a GP from London, said, “This study was conducted to see how feasible and useful CRP POCT is in real world general practice. We found that the test could be easily incorporated into routine care and provided very useful information for GPs and patients presenting with a cough. The vast majority of patients were reassured by a low CRP level and did not receive antibiotics.” The study was presented at the Royal College of General Practitioners (RCGP) Annual Conference held October 1-3, 2015, in Glasgow (UK).
Related Links:
Alere
Almost 80% of antibiotics are prescribed in primary care and respiratory tract infections (RTIs) are the reason for 60% of these antibiotic prescriptions. The vast majority of these infections are self-limiting or caused by viruses in which case antibiotics have little or no clinical benefit for patients. C-reactive protein point of care testing (CRP POCT) has successfully helped to identify patients who did not require antibiotics, when presenting with symptoms of RTIs.
A study that was recently conducted that included 99 patients, aged 5 to 75 years who visited their general practitioner (GP) with a chesty cough. After undergoing a clinical scoring system, each patient's CRP levels were measured at the point of care using the Afinion CRP test, a rapid in vitro diagnostic assay for quantitative determination of CRP (Alere; Waltham, MA, USA). Only 13% of these patients needed antibiotic treatment as the CRP POCT had concluded higher CRP levels. Within one month, 17% of the 99 patients returned to the surgery and only 5% were prescribed antibiotics.
The study also provides insights on patients' expectations of receiving antibiotics. All participants had to complete a questionnaire in which they were asked whether they expected to receive antibiotics for their symptoms. Of the 26 patients expecting to receive antibiotics, only seven (27%) patients received them. Additionally, patients with lower CRP levels, who therefore would not have been suitable for antibiotics, were more likely to expect an antibiotic when asked.
CRP POCT takes less than five minutes from a finger stick blood sample to provide a quantitative result and helps to facilitate an effective conversation between patients and GPs around the rational use of antibiotics. The CRP POCT is already used in routine management in several European countries to aid diagnosis in suspected RTI and guide decision making regarding antibiotic prescribing.
Rob Cook, MD, who was involved in the study and a GP from London, said, “This study was conducted to see how feasible and useful CRP POCT is in real world general practice. We found that the test could be easily incorporated into routine care and provided very useful information for GPs and patients presenting with a cough. The vast majority of patients were reassured by a low CRP level and did not receive antibiotics.” The study was presented at the Royal College of General Practitioners (RCGP) Annual Conference held October 1-3, 2015, in Glasgow (UK).
Related Links:
Alere
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Microbiology News
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia
- Rapid AST Platform Provides Targeted Therapeutic Results Days Faster Than Current Standard of Care
- New Analysis Method Detects Pathogens in Blood Faster and More Accurately by Melting DNA